Privacy Policy
Jazz Pharmaceuticals respects the privacy of visitors to its website. We will not collect any personal information about you, unless you provide it. Certain domain information may be collected solely to monitor website usage and improve our website. If you choose to submit personal information to us, we will use it to respond to your inquiries. We will not provide or sell the information to others and will comply with all applicable laws regarding uses of personal information. If you have any questions or concerns about our privacy policy, please contact us at contact@jazzpharma.com.

Our Mission
- Improve patients' lives
- Develop valuable products in psychiatry and neurology
- Always keep patients firmly in mind
Our Inspiration
- Addressing poorly understood conditions and underserved patients
- Improving patient care and developing valuable programs for physicians and patients
News
06/24/2009 | Press ReleaseJazz Pharmaceuticals and UCB Announce Second Phase III Study of Sodium Oxybate in Patients With Fibromyalgia Meets Primary Endpoints
06/15/2009 | Press Release
Data Suggest Sodium Oxybate Significantly Improves Pain and the Core Symptoms of Fibromyalgia
06/09/2009 | Press Release
Jazz Pharmaceuticals to Present Data From First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia